13,230 Shares in Axon Enterprise, Inc $AXON Bought by Moran Wealth Management LLC

Moran Wealth Management LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the first quarter, HoldingsChannel reports. The institutional investor acquired 13,230 shares of the biotechnology company’s stock, valued at approximately $5,619,000.

Several other institutional investors have also recently added to or reduced their stakes in AXON. Creative Financial Designs Inc. ADV acquired a new stake in Axon Enterprise during the fourth quarter worth about $28,000. Sound Income Strategies LLC boosted its stake in Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after acquiring an additional 44 shares during the period. Camelot Portfolios LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $30,000. AlphaCentric Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $34,000. Finally, Lodestone Wealth Management LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $35,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $597.04 on Friday. The stock has a market cap of $48.12 billion, a price-to-earnings ratio of 239.78, a PEG ratio of 12.18 and a beta of 1.38. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The stock’s 50 day moving average price is $437.68 and its 200 day moving average price is $482.40.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million during the quarter, compared to analysts’ expectations of $778.90 million. During the same quarter last year, the business posted $1.47 earnings per share. The company’s quarterly revenue was up 33.7% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on AXON shares. Weiss Ratings raised Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Piper Sandler restated an “overweight” rating and set a $674.00 price objective on shares of Axon Enterprise in a research note on Monday, June 15th. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a research report on Thursday, May 7th. Finally, UBS Group cut their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Insider Transactions at Axon Enterprise

In related news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the transaction, the insider directly owned 52,813 shares of the company’s stock, valued at approximately $21,125,200. The trade was a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CRO Cameron Brooks sold 1,242 shares of the company’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $621,000.00. Following the completion of the transaction, the executive owned 49,710 shares in the company, valued at $24,855,000. This represents a 2.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 48,989 shares of company stock worth $24,090,083 in the last three months. Insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.